Trials / Conditions / Fallopian Tube Endometrioid Tumor
Fallopian Tube Endometrioid Tumor
4 registered clinical trials studyying Fallopian Tube Endometrioid Tumor — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary NCT04575935 | M.D. Anderson Cancer Center | Phase 3 |
| Active Not Recruiting | Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurr NCT04034927 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ova NCT03685695 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavi NCT02111941 | Mayo Clinic | EARLY_Phase 1 |